Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Alzheimer Disease

The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it?

This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.

The Conversation

Australia approves new drug to treat early Alzheimer’s disease

Kisunla is first new treatment registered by TGA in 25 years but could cost patients more than $80,000 and less than one in five will be eligible

The Guardian - AU

Could cold sores increase the risk of Alzheimer’s disease? A new study is no cause for panic

A new study has found the herpes simplex virus type 1 (HSV-1), which causes cold sores, may be linked to the development of Alzheimer’s disease.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Scientists ‘slash risk of Alzheimer’s’ with medicine used to treat cold sores

Researchers made a surprising connection between certain viral diseases and Alzheimer’s

The Independent UK

Treating cold sores with anti-virals ‘may slash risk of developing Alzheimer’s’

A study found that people who had suffered the herpes virus had an 80% increased risk of Alzheimer’s disease.

Evening Standard

Should AD stand for Alzheimer’s disease, or for Auguste Deter, the patient whose case was first described?

Auguste Deter was born 175 years ago on May 16, 1850. Though the story of her life is not widely known, it should be. Through her suffering and dignity, Deter puts a much-needed human face on the tragedy of Alzheimer’s disease (AD), one of the most important medical problems currently…

The Conversation

Do people really want to know their risk of getting Alzheimer’s?

A new study has highlighted the complex emotions and ethical dilemmas of learning your future risk of Alzheimer’s disease. Among 274 healthy research participants from the US aged 65 and over, 40% declined to receive their personal risk estimates – despite having initially expressed an interest in doing so.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Alzheimer’s: certain combinations of prescription drugs may slow progression of the disease, says mice study

Millions of older adults take five or more prescription drugs every day to manage chronic illnesses. While polypharmacy is often necessary, this practice has also been linked to many negative health outcomes in older adults – including memory problems, increased risk of falls and greater frailty.

The Conversation

How menopause symptoms could predict women’s risk of dementia

ANALYSIS: Menopause can provide early warning signs, write Jasper Crockford, Maryam Ghahremani and Zahinoor Ismail

The Independent UK

Diabetes drugs offer new hope for Aussies with dementia

Diabetes treatments are offering a glimmer of hope for a degenerative brain condition set to affect more than 800,000 Australians by the middle of the century.

AAP

Early-onset Alzheimer’s: new drug shows promise in slowing the disease

Alzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset Alzheimer’s disease progresses more rapidly and often strikes people in the prime of their lives. Treatment options remain limited.

The Conversation

New drug could reduce risk of early-onset Alzheimer’s disease

The results boost hopes similar treatments being developed to target more common forms of Alzheimer's - that appear when people reach their sixties, seventies and eighties - might also be effective.

The Independent UK

Changes to speech and language can help detect Alzheimer’s early – here are five things to look out for

Ten million people are diagnosed with dementia worldwide each year – that’s more than ever. According to the Alzheimer’s Society approximately one million people in the UK are currently living with the disease. Studies predict this figure will rise to 1.6 million people by 2050.

The Conversation

Alzheimer’s research centers face Trump-imposed $65m funding delay across the US

Researchers report difficulties retaining staff as White House cost-cutting stresses US medical research system

The Guardian - US

Get all your
news in one place.

100’s of premium titles.
One news app.

The Times of India

Can a 19-year-old develop Alzheimer's disease? What causes early-onset disease in young

Alzheimer's disease is known to affect the elderly, and one would never expect a teenage individual to develop the neurodegenerative condition. However, this extremely rare case happened in China, and the researchers are yet to understand its underlying cause.

The Times of India

Could Alzheimer’s begin in your mouth? Research uncovers a potential bacterial trigger

Can you get Alzheimer's disease from a gum infection? While the link may seem far-fetched, a new study has uncovered this lesser-known connection, offering clues to the roots of the neurodegenerative disease.

LiveScience

Man nearly guaranteed to get early Alzheimer's is still disease-free in his 70s — how?

A man who should have developed early-onset Alzheimer's disease due to a genetic mutation is still symptom-free in his 70s. Scientists are trying to understand why.

Fortune

Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drug

Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same age their parents did.

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

It's not just forgetfulness: 8 early warning signs of dementia

Nightmares and changes in vision can both be early warning signs of dementia.

The Times of India

Inhaling this gas could help treat Alzheimer's disease, study suggests

A simple out-of-the-box treatment for Alzheimer's disease has been discovered by scientists which could help activate brain cells that assist in breaking down plaques and reducing inflammation associated with the neurodegenerative disease.

The Times of India

Thyroid, liver proteins help maintain brain health and help treat Alzheimer’s, study reveals

The recent study that links thyroid and liver proteins with brain functioning has promised a new approach to tackling Alzheimer’s disease. Certain thyroid and liver proteins have been discovered to be of high importance when it comes to moderation of the cognitive ability as well as providing protection against neurodegenerative…

Salon

Alzheimer’s may not be from amyloids

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease

The Times of India

Alzheimer's could be reversed, say researchers as study finds cellular mechanism behind it

A study published in the journal Neuron has found the cellular mechanism that links stress in the brain to the progression of Alzheimer's disease. This breakthrough can promise a major boost in the treatment of the disease.

Medical Daily

Jobs That Save Lives? People In Certain Professions May Be At Reduced Risk Of Alzheimer's Death

Professions requiring constant navigation, such as taxi and ambulance drivers, might be at an advantage as a recent study found these workers have a reduced risk of death from Alzheimer's disease.

Tom’s Guide

New study will use phone apps to explore link between sleep and Alzheimer's risk

Cambridge University and UCL will collaborate with a tech company to explore how sleep tracking data can help detect Alzheimer's disease

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

the Alzheimer Association

37 stories

The Therapeutic Goods Administration

22 stories

University of Calgary

15 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.